Clinical trial
Renal and Systemic Effects of NCX4016 in Patients With Type 2 Diabetes and Early…
NCT00157508 · Mario Negri Institute for Pharmacological Research, Other · Terminated
Key facts
| NCT number | NCT00157508 |
|---|---|
| Title | Renal and Systemic Effects of NCX4016 in Patients With Type 2 Diabetes and Early Nephropathy |
| Official title | A Pilot, Randomised, Double-blind, Cross-over Study to Assess the Renal and Systemic Effects of NCX4016 in Patients With Type 2 Diabetes and Early Nephropathy |
| Lead sponsor | Mario Negri Institute for Pharmacological Research, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes, Early Nephropathy |
| Intervention type | Drug |
| Interventions | nitroaspirin |
| Enrollment | 13 |
| Start date | Mar 1, 2003 |
| Completion | Aug 1, 2004 |
| First posted | Sep 12, 2005 |
| Last update posted | Apr 9, 2015 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: